Thermo Fisher Scientific Inc.

TMO Healthcare Diagnostics & Research

Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024.

Revenue
+9.13%
EPS
+8.64%
Free cash flow
+15.0%
Total debt
+22.8%

Quarter to September 2026, against a year earlier

679.52 26.64 −3.77%
Market cap
$250.8B
P/E
35.8×
Fwd P/E
35.7×
Dividend yield
0.27%
F-score
5/9
Altman Z
3.84
Beneish M
−2.46
Dividend safety
88/100

Thermo Fisher Scientific Inc. (TMO) Book value per share

Alert me on Book value per share

Thermo Fisher Scientific Inc.'s book value per share at the end of fiscal 2025 was 142×, up 9.23% from 130× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 148×. Over the past ten years it has ranged from 53.5× (fiscal 2015) to 142× (fiscal 2025) — the current reading is the highest in ten years. Thermo Fisher Scientific Inc. ranks 2nd of 49 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 142× 9.23%
FY2024 130× 7.16%
FY2023 121× 7.76%
FY2022 112× 8.33%
FY2021 104× 18.96%
FY2020 87.2× 17.49%
FY2019 74.2× 8.11%
FY2018 68.6× 6.66%
FY2017 64.3× 17.98%
FY2016 54.5× 1.91%

Quarterly newest first

Period Book value per share Change
Sep 2026 148× 4.23%
Jun 2026 142× 1.71%
Mar 2026 140× (1.45%)
Dec 2025 142× 4.96%
43 more quarters

Against its own ten years

Low 53.5× High 142×
Ten-year median 87.2×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on TMO